Astera Labs (ALAB) EBIAT (2023 - 2025)
Astera Labs (ALAB) has disclosed EBIAT for 3 consecutive years, with $45.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT rose 82.02% year-over-year to $45.0 million, compared with a TTM value of $219.1 million through Dec 2025, up 362.68%, and an annual FY2025 reading of $219.1 million, up 362.68% over the prior year.
- EBIAT was $45.0 million for Q4 2025 at Astera Labs, down from $91.1 million in the prior quarter.
- Across five years, EBIAT topped out at $91.1 million in Q3 2025 and bottomed at -$93.0 million in Q1 2024.
- Average EBIAT over 3 years is $9.1 million, with a median of $5.6 million recorded in 2023.
- The sharpest move saw EBIAT plummeted 432.8% in 2024, then soared 1299.97% in 2025.
- Year by year, EBIAT stood at $14.3 million in 2023, then soared by 72.52% to $24.7 million in 2024, then surged by 82.02% to $45.0 million in 2025.
- Business Quant data shows EBIAT for ALAB at $45.0 million in Q4 2025, $91.1 million in Q3 2025, and $51.2 million in Q2 2025.